(Q45987670)

18 December 2017

title

Vascular endothelial growth factor is essential for corpus luteum angiogenesis. (English)

1 reference

18 December 2017

0 references

1 reference

Ferrara N

1 reference

18 December 2017

Chen H

1 reference

18 December 2017

Davis-Smyth T

1 reference

18 December 2017

Gerber HP

1 reference

18 December 2017

Nguyen TN

1 reference

18 December 2017

Peers D

1 reference

18 December 2017

Chisholm V

1 reference

18 December 2017

Hillan KJ

1 reference

18 December 2017

Schwall RH

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

18 December 2017

published in

Nature Medicine

1 reference

18 December 2017

volume

1 reference

18 December 2017

issue

1 reference

18 December 2017

page(s)

336-340

1 reference

18 December 2017

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

Designing CD4 immunoadhesins for AIDS therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

Production a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

7 January 2021

The biology of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

7 January 2021

Vascular endothelial growth factor is expressed in rat corpus luteum

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

7 January 2021

Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

7 January 2021

Corpus luteum angiogenic factor is related to fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

7 January 2021

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

7 January 2021

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

7 January 2021

The regulation of the mammalian corpus luteum.

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

7 January 2021

Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

7 January 2021

Essential role of growth hormone in ischemia-induced retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

7 January 2021

Ovarian hyperstimulation syndrome. Report of a case with notes on pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

7 January 2021

Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNM0398-336

7 January 2021

Identifiers

DOI

10.1038/NM0398-336

1 reference

18 December 2017

Dimensions Publication ID

1001019213

0 references

1 reference

18 December 2017